Suplementación de Coenzima Q10 (CoQ10) como profilaxis en pacientes adultos con migraña: un breve meta análisis actualizado
Star of Sciences Multidisciplinary Journal · 30.12.2025 · 2 (2) · 1-12
DOI: 10.63969/43673716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Star of Sciences Multidisciplinary Journal, online erschienen am 30.12.2025. Verfasst von Angelo Israel García Purcachi und 5 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Migraine is a common and disabling neurological disorder, largely related to pathophysiological mechanisms involving oxidative stress and mitochondrial dysfunction. Coenzyme Q10 (CoQ10), due to its role in the mitochondrial electron transport chain, has been proposed as a prophylactic treatment strategy; however, the available evidence remains inconsistent.
Methods
A systematic review and meta-analysis of double-blind randomized controlled trials was conducted, comparing CoQ10 supplementation with placebo in adults with migraine diagnosed according to International Headache Society (IHS) criteria. Primary outcome: Monthly frequency of migraine attacks after treatment. Secondary outcome: Pain severity during migraine attacks. Random- effects models were applied. Methodological quality was assessed using RoB 2.0, and certainty of evidence was evaluated with the GRADE approach.
Results
Seven randomized clinical trials involving 510 patients were included. Five studies (329 patients) demonstrated a significant reduction in monthly migraine frequency in favor of CoQ10 (MD: −0.84; 95% CI −1.62 to −0.05; p = 0.04; I² = 0%). Additionally, five trials (324 patients) showed a moderate but statistically significant reduction in pain severity measured by the visual analog scale (VAS) (SMD: −0.17; 95% CI −0.33 to −0.01; p = 0.05; I² = 0%).
Conclusions
CoQ10 supplementation is associated with a reduction in monthly migraine attack frequency in adults, supporting its use as a complementary prophylactic strategy in migraine.
Zitieren
APA
Purcachi, A. I. G., Aguayo, G. E. F., Moran, D. K. P., Torres, J. F. Y., Mendoza, C. D. C., & Ulloa, I. R. G. (2025). Suplementación de Coenzima Q10 (CoQ10) como profilaxis en pacientes adultos con migraña: un breve meta análisis actualizado. Star of Sciences Multidisciplinary Journal, 2(2), 1-12. https://doi.org/10.63969/43673716
Vancouver
Purcachi AIG, Aguayo GEF, Moran DKP, Torres JFY, Mendoza CDC, Ulloa IRG. Suplementación de Coenzima Q10 (CoQ10) como profilaxis en pacientes adultos con migraña: un breve meta análisis actualizado. Star of Sciences Multidisciplinary Journal. 2025;2(2):1-12. doi:10.63969/43673716
BibTeX
@article{Purcachi2025,
author = {Purcachi, Angelo Israel García and Aguayo, Genesis Elena Franco and Moran, Denisse Katherine Pinzon and Torres, Jimmy Fernando Yaguana and Mendoza, Christian David Cevallos and Ulloa, Israel Rollin Guerrero},
title = {Suplementación de Coenzima Q10 (CoQ10) como profilaxis en pacientes adultos con migraña: un breve meta análisis actualizado},
journal = {Star of Sciences Multidisciplinary Journal},
year = {2025},
volume = {2},
number = {2},
pages = {1--12},
doi = {10.63969/43673716}
}
EUVIMED